semaglutide for autoimmune disease GLP-1 Agonists Improving Metabolic Health with GLP-1 with Hashimoto's Disease: Safety

PMID: 33459204

For annuities and pensions, however, increased longevity may pose a risk to carriers, potentially affecting profitability on products tied to life expectancy

Some patients experience therapeutic benefitsincluding weight loss and improved blood glucosewithout significant nausea or other side effects, particularly when dose escalation follows the recommended gradual schedule

SankodaAHaradaNIwasakiKYamaneSMurataYShibueKet al

Yet, sleep and weight are strongly associated with one another, especially as we age

Additionally, metabolic rates tend to slow with age, making weight gain easier and weight loss more challenging